Gilead Sciences (GILD) Fails to deliver data

Key failure to deliver metrics for Gilead Sciences:

• Last SEC data release: 2025-12-31
• Last 15 days FTD volume: A$1.63 M
• Last 3 months FTD volume: A$30.94 M
• Last 12 months FTD volume: A$0.24 B

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Gilead Sciences (GILD) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Gilead Sciences (GILD) - since 2013

Gilead Sciences (GILD) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Amgen AMGN	A$78.98 M	A$0.25 B	🇺🇸 USA
Vertex Pharmaceuticals VRTX	A$37.57 M	A$0.10 B	🇺🇸 USA
AbbVie ABBV	A$37.45 M	A$88 M	🇺🇸 USA
Illumina ILMN	A$2.54 M	A$15.43 M	🇺🇸 USA
Biogen BIIB	A$3.68 M	A$75.95 M	🇺🇸 USA
Pfizer PFE	A$55.69 M	A$0.12 B	🇺🇸 USA
Johnson & Johnson JNJ	A$32.98 M	A$0.10 B	🇺🇸 USA
Eli Lilly LLY	A$0.22 B	A$0.41 B	🇺🇸 USA
Merck MRK	A$36.84 M	A$0.14 B	🇺🇸 USA